logo
Select company
Select metric
-98.91%Return on Assets
VS
Market
7
Sector
20
Industry
26
History
33
$ 1.02Close
$ 0.85 - $ 4.86 52-Week Range
Ticker Information

Ticker

MRKR

Company Name

MARKER THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MARKER THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRKR - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 14.77M$ -14.61M-98.91%
3/31/2025$ 16.99M$ -12.78M-75.23%
12/31/2024$ 22.02M$ -10.73M-48.73%
9/30/2024$ 10.91M$ -9.7M-88.88%
6/30/2024$ 11.68M$ -10.37M-88.83%
3/31/2024$ 14.09M$ -5.66M-40.18%
12/31/2023$ 17.13M$ -8.24M-48.09%
9/30/2023$ 19.49M$ -9.29M-47.67%
6/30/2023$ 21.96M$ -13.23M-60.25%
3/31/2023$ 27.94M$ -24.99M-89.43%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MARKER THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -52.04%.
  • Over the past 5 years, MARKER THERAPEUTICS INC's average ROA has been -66.49%.
  • The median ROA for MARKER THERAPEUTICS INC during this period was -62.2%
  • MARKER THERAPEUTICS INC reached its highest ROA over the past 5 years at -35.08%.
  • The lowest ROA recorded by MARKER THERAPEUTICS INC in the same timeframe -98.91%

MARKER THERAPEUTICS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
LPCN : LIPOCINE INC -24.26%BOLT : BOLT BIOTHERAPEUTICS INC -67.17%XAIR : BEYOND AIR INC -149.8%TRAW : TRAWS PHARMA INC 562.73%INM : INMED PHARMACEUTICALS INC -52.39%LGVN : LONGEVERON INC -111.58%LEXX : LEXARIA BIOSCIENCE CORP -168.97%NBY : NOVABAY PHARMACEUTICALS INC 33.56%NRXS : NEURAXIS INC -110.11%IBIO : IBIO INC -79.26%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for MARKER THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -25.28M ] / Assets [ $ 48.57M ]
(=) ROA [ -52.04% ]

MRKR - Return on Assets, Last 5 years

-98.91%

Minimum

Jun 30, 2025

-35.08%

Maximum

Mar 31, 2021

-66.49%

Average

-62.2%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.44K
min-33.4%
max33.98%
average0.12%
median1.53%
std10.61%